Filters: keyword is Blood-Brain Barrier [Clear All Filters]
- 2008
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments,
J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30.
Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat,
Pharm Res, vol. 25, no. 4, pp. 792-804.
- 2005
Targeting liposomes with protein drugs to the blood-brain barrier in vitro,
Eur J Pharm Sci, vol. 25, no. 2-3, pp. 299-305.
- 2004
Population pharmacokinetic modeling of blood-brain barrier transport of synthetic adenosine A1 receptor agonists,
J Pharmacol Exp Ther, vol. 311, no. 3, pp. 1138-46.
Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro,
J Drug Target, vol. 12, no. 3, pp. 145-50.
- 2003
Characterization of the pharmacokinetics, brain distribution, and therapeutic efficacy of the adenosine A1 receptor partial agonist 2'-deoxy-N6-cyclopentyladenosine in sarin-poisoned rats,
Toxicol Appl Pharmacol, vol. 192, no. 1, pp. 86-94.
Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: structure transport relationships,
Eur J Pharm Sci, vol. 20, no. 3, pp. 347-56.
Functional role of adenosine receptor subtypes in the regulation of blood-brain barrier permeability: possible implications for the design of synthetic adenosine derivatives,
Eur J Pharm Sci, vol. 19, no. 1, pp. 13-22.
- 2002
Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain,
Clin Pharmacokinet, vol. 41, no. 10, pp. 691-703.
- 1997
Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier,
Brain Res Brain Res Rev, vol. 25, no. 1, pp. 27-49.
- 1995
The use of intracerebral microdialysis to determine changes in blood-brain barrier transport characteristics,
Pharm Res, vol. 12, no. 1, pp. 129-33.
Repeated microdialysis perfusions: periprobe tissue reactions and BBB permeability,
Brain Res, vol. 702, no. 1-2, pp. 261-5.
- 1994
Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain,
Brain Res, vol. 666, no. 1, pp. 1-8.
- 1993
Drug transport across the blood-brain barrier. III. Mechanisms and methods to improve drug delivery to the central nervous system,
Pharm World Sci, vol. 15, no. 1, pp. 2-9.
The use of intracerebral microdialysis to study blood-brain barrier transport in health, after modification and in disease,
Adv Exp Med Biol, vol. 331, pp. 257-62.
- 1992
Drug transport across the blood--brain barrier. I. Anatomical and physiological aspects,
Pharm Weekbl Sci, vol. 14, no. 5, pp. 305-10.
Drug transport across the blood-brain barrier. II. Experimental techniques to study drug transport,
Pharm Weekbl Sci, vol. 14, no. 6, pp. 338-48.
- 1991
Stereoselective transport of baclofen across the blood-brain barrier in rats as determined by the unit impulse response methodology,
Pharm Res, vol. 8, no. 2, pp. 259-62.
- 1990
Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology,
Pharm Res, vol. 7, no. 3, pp. 293-8.
- 1989
Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells,
J Pharmacol Exp Ther, vol. 249, no. 3, pp. 901-5.
- 1988
Altered pharmacokinetic-pharmacodynamic relationship of heptabarbital in experimental renal failure in rats,
J Pharmacol Exp Ther, vol. 246, no. 1, pp. 371-6.
Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs,
J Pharmacol Exp Ther, vol. 247, no. 3, pp. 1233-9.



